{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:56:16Z","timestamp":1753890976912,"version":"3.41.2"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.02099","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T04:46:42Z","timestamp":1598590002000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case Report: Adult Still\u2019s Disease in an Alemtuzumab-Treated Multiple Sclerosis Patient"],"prefix":"10.3389","volume":"11","author":[{"given":"Julia","family":"Kr\u00e4mer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja","family":"Kr\u00f6mer-Olbrisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz-J\u00fcrgen","family":"Lakomek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter D.","family":"Schellinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Foell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven G.","family":"Meuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Straeten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1212\/WNL.0000000000004354","article-title":"Alemtuzumab CARE-MS II 5-year follow-up: efficacy and safety findings.","volume":"89","author":"Coles","year":"2017","journal-title":"Neurology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1177\/1352458518804124","article-title":"Sarcoidosis following alemtuzumab treatment: autoimmunity mediated by T cells and interferon-gamma.","volume":"24","author":"Pfeuffer","year":"2018","journal-title":"Mult Scler."},{"key":"B3","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1212\/WNL.0000000000005420","article-title":"Hemophagocytic lymphohistiocytosis in 2 patients with multiple sclerosis treated with alemtuzumab.","volume":"90","author":"Saarela","year":"2018","journal-title":"Neurology."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000657","article-title":"A case of idiopathic multicentric Castleman disease in an alemtuzumab-treated patient with MS.","volume":"7","author":"Rolfes","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jaut.2018.07.018","article-title":"A comprehensive review on adult onset Still\u2019s disease.","volume":"93","author":"Giacomelli","year":"2018","journal-title":"J Autoimmun."},{"key":"B6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12016-019-08747-8","article-title":"Autoinflammatory pathogenesis and targeted therapy for adult-onset still\u2019s disease.","volume":"58","author":"Li","year":"2019","journal-title":"Clin Rev Allergy Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10067-015-3108-6","article-title":"Serum calprotectin\u2014a promising diagnostic marker for adult-onset Still\u2019s disease.","volume":"35","author":"Qian","year":"2016","journal-title":"Clin Rheumatol."},{"key":"B8","first-page":"424","article-title":"Preliminary criteria for classification of adult Still\u2019s disease.","volume":"19","author":"Yamagushi","year":"1992","journal-title":"J Rheumatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/00005792-200205000-00003","article-title":"Proposal for a new set of classification criteria for adult-onset still disease.","volume":"81","author":"Fautrel","year":"2002","journal-title":"Medicine (Baltimore)."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00253","article-title":"Best practices for long-term monitoring and follow-up of alemtuzumab-treated ms patients in real-world clinical settings.","volume":"10","author":"Barclay","year":"2019","journal-title":"Front Neurol."},{"journal-title":"Measures to Minimise Risk of Serious Side Effects of Multiple Sclerosis Medicine Lemtrada.","year":"","key":"B11"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1177\/1352458519851219","article-title":"Emerging safety issues in alemtuzumab- treated MS patients.","volume":"25","author":"Killestein","year":"2019","journal-title":"Mult Scler."},{"key":"B13","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1080\/14737159.2019.1615449","article-title":"The role of damage-associated molecular pattern for pathogenesis and biomarkers in adult-onset Still\u2019s disease.","volume":"19","author":"Jung","year":"2019","journal-title":"Expert Rev Mol Diagn."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01990","article-title":"Systematic review of safety and efficacy of rituximab in treating immune-mediated disorders.","volume":"10","author":"Kaegi","year":"2019","journal-title":"Front Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/rheumatology\/key306","article-title":"Use and effectiveness of rituximab in children and young people with juvenile idiopathic arthritis in a cohort study in the United Kingdom.","volume":"58","author":"Kearsley-Fleet","year":"2019","journal-title":"Rheumatology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1080\/21548331.2018.1451205","article-title":"DRESS syndrome: a detailed insight.","volume":"46","author":"Behera","year":"2018","journal-title":"Hosp Pract."},{"key":"B17","doi-asserted-by":"publisher","first-page":"879","DOI":"10.4414\/fms.2011.07693","article-title":"DRESS (Drug Rash with Eosinophilia and Systemic Symptoms) \u2013 Eine schwere, oft verkannte Medikamentenallergie.","volume":"11","author":"Pichler","year":"2011","journal-title":"Schweiz Med Forum."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18061243","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an interplay among drugs, viruses, and immune system.","volume":"18","author":"Cho","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.alit.2019.03.006","article-title":"Drug-induced hypersensitivity syndrome (DiHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): an update in 2019.","volume":"68","author":"Shiohara","year":"2019","journal-title":"Allergol Int."},{"key":"B20","first-page":"66","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) in children.","volume":"90","author":"Mori","year":"2019","journal-title":"Acta Biomed."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.02099\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T04:46:46Z","timestamp":1598590006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.02099\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,28]]},"references-count":20,"alternative-id":["10.3389\/fimmu.2020.02099"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.02099","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2020,8,28]]},"article-number":"2099"}}